12 Health Care Stocks Moving In Thursday’s Pre-Market Session

Start Trading with HYCM Today!

Gainers

n

    n

  • Tenax Therapeutics (NASDAQ:TENX) shares rose 153.2% to $4.28 during Thursday’s pre-market session. The company’s market cap stands at $9.8 million.
  • n

  • Biophytis (NASDAQ:BPTS) stock rose 119.45% to $0.9. The company’s market cap stands at $18.3 million. The company’s, H1 earnings came out 2 days ago.
  • n

  • Lannett (NYSE:LCI) stock rose 37.22% to $0.74. The market value of their outstanding shares is at $31.0 million. The company’s, Q2 earnings came out yesterday.
  • n

  • Rockwell Medical (NASDAQ:RMTI) shares rose 30.81% to $2.08. The company’s market cap stands at $24.1 million.
  • n

  • Science 37 Hldgs (NASDAQ:SNCE) stock moved upwards by 24.9% to $0.67. The company’s market cap stands at $78.1 million.
  • n

  • Align Tech (NASDAQ:ALGN) stock moved upwards by 15.52% to $326.39. The company’s market cap stands at $25.4 billion. As per the press release, Q4 earnings came out yesterday.
  • n

n

Losers

n

    n

  • OncoSec Medical (NASDAQ:ONCS) stock declined by 28.2% to $1.53 during Thursday’s pre-market session. The company’s market cap stands at $4.5 million.
  • n

  • TransCode Therapeutics (NASDAQ:RNAZ) stock declined by 24.87% to $0.65. The company’s market cap stands at $8.4 million.
  • n

  • AnPac Bio-Medical Science (NASDAQ:ANPC) stock declined by 14.39% to $7.5. The company’s market cap stands at $15.2 million.
  • n

  • Vera Therapeutics (NASDAQ:VERA) stock declined by 13.31% to $7.36. The market value of their outstanding shares is at $203.5 million.
  • n

  • Adial Pharmaceuticals (NASDAQ:ADIL) shares fell 12.94% to $0.4. The market value of their outstanding shares is at $10.7 million.
  • n

  • Ambrx Biopharma (NYSE:AMAM) shares decreased by 8.52% to $1.72. The market value of their outstanding shares is at $66.4 million. nSee Also: www.benzinga.com/money/best-healthcare-stocks/
  • n

n

This article was generated by Benzinga’s automated content engine and reviewed by an editor.